Physician profile
Christopher Adams
NPI 1720039175
$20,831.84
in general payments reported to CMS, 2019-2025
37 companies · $3,978 in 2025
The $3,978 reported for 2025 was more than what 83% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,464 · 2020: $1,500 · 2021: $2,032 · 2022: $3,150 · 2023: $3,759 · 2024: $3,949 · 2025: $3,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,615.95 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,366.56 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Amgen INC. | $3,150.43 | 2019-2025 | Enbrel, Tavneos, Evenity |
| Ucb, INC. | $2,008.26 | 2019-2025 | Cimzia, Bimzelx |
| Pfizer INC. | $1,383.70 | 2019-2025 | |
| Janssen Biotech, INC. | $1,375.67 | 2019-2025 | Tremfya, Simponi Aria |
| Glaxosmithkline, LLC. | $1,193.84 | 2019-2025 | Benlysta |
| Mallinckrodt Hospital Products INC. | $1,140.64 | 2021-2025 | Acthar |
| Astrazeneca Pharmaceuticals LP | $833.25 | 2021-2025 | Saphnelo, Evusheld |
| Novartis Pharmaceuticals Corporation | $809.05 | 2019-2025 | |
| Radius Health, INC. | $754.75 | 2019-2025 | Tymlos |
| E.R. Squibb & Sons, L.L.C. | $753.12 | 2019-2025 | Orencia |
| Ani Pharmaceuticals, INC. | $719.64 | 2022-2025 | Purified Cortrophin Gel |
| Lilly USA, LLC | $685.31 | 2019-2025 | Taltz, Zepbound |
| Aurinia Pharma U.S., INC. | $477.42 | 2021-2025 | Lupkynis |
| Horizon Therapeutics Plc | $466.40 | 2019-2023 | Krystexxa |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.